| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity
|
Yeral, Mahmut
|
|
|
20 |
10 |
p. 652-660
|
artikel
|
| 2 |
A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL)
|
Beltrán, Brady E.
|
|
|
20 |
10 |
p. 637-646
|
artikel
|
| 3 |
A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide
|
Gamberi, Barbara
|
|
|
20 |
10 |
p. e629-e644
|
artikel
|
| 4 |
A Real-world Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML
|
Das, Nupur
|
|
|
20 |
10 |
p. e673-e684
|
artikel
|
| 5 |
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis
|
Stelmach, Patrick
|
|
|
20 |
10 |
p. e724-e733
|
artikel
|
| 6 |
Childhood Therapy–Related Acute Myeloid Leukemia with t(16;21)(q24;q22)/RUNX1-CBFA2T3 After a Primitive Neuroectodermal Tumor of the Chest Wall
|
Crisci, Stefania
|
|
|
20 |
10 |
p. e660-e666
|
artikel
|
| 7 |
De Novo CD5+ Diffuse Large B-Cell Lymphoma: Biology, Mechanism, and Treatment Advances
|
Xu, Yichen
|
|
|
20 |
10 |
p. e782-e790
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
20 |
10 |
p. A1-A2
|
artikel
|
| 9 |
Effects of Distance From Academic Cancer Center on Overall Survival of Acute Myeloid Leukemia: Retrospective Analysis of Treated Patients
|
Dhakal, Prajwal
|
|
|
20 |
10 |
p. e685-e690
|
artikel
|
| 10 |
Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Waldenström Macroglobulinemia: A Systematic Review and Meta-analysis
|
Parrondo, Ricardo D.
|
|
|
20 |
10 |
p. e694-e711
|
artikel
|
| 11 |
Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab
|
Moore, Donald C.
|
|
|
20 |
10 |
p. e777-e781
|
artikel
|
| 12 |
Excellent Outcomes with Surgery or Radiotherapy in the Management of Castleman Disease Including a Case of Oligocentric Disease
|
Beckham, Thomas H.
|
|
|
20 |
10 |
p. 685-689
|
artikel
|
| 13 |
Influence of Rurality, Race, and Ethnicity on Non-Hodgkin Lymphoma Incidence
|
Blansky, Deanna
|
|
|
20 |
10 |
p. 668-676.e5
|
artikel
|
| 14 |
Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis
|
Bewersdorf, Jan Philipp
|
|
|
20 |
10 |
p. e712-e723
|
artikel
|
| 15 |
JAK2, CALR, and MPL Mutations in Egyptian Patients With Classic Philadelphia-negative Myeloproliferative Neoplasms
|
Soliman, Eman A.
|
|
|
20 |
10 |
p. e645-e651
|
artikel
|
| 16 |
Pituitary Apoplexy During Hematopoietic Cell Transplantation
|
Patel, Aneri
|
|
|
20 |
10 |
p. e691-e693
|
artikel
|
| 17 |
Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in China
|
Yu, Tengteng
|
|
|
20 |
10 |
p. e652-e659
|
artikel
|
| 18 |
Racial Disparities in the Utilization of Novel Agents for Frontline Treatment of Multiple Myeloma
|
Fiala, Mark A.
|
|
|
20 |
10 |
p. 647-651
|
artikel
|
| 19 |
Real World Outcomes in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Receiving Palliative Intent Therapies
|
Ayers, Emily C.
|
|
|
20 |
10 |
p. 661-667
|
artikel
|
| 20 |
Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera
|
Coltoff, Alexander
|
|
|
20 |
10 |
p. 697-703.e1
|
artikel
|
| 21 |
Role of Allogeneic HCT as Postremission Therapy for Transplant-Eligible Adult Lymphoblastic Leukemia/Lymphoma After Frontline Hyper-CVAD
|
Damlaj, Moussab
|
|
|
20 |
10 |
p. 690-696
|
artikel
|
| 22 |
Role of the Bone Marrow Milieu in Multiple Myeloma Progression and Therapeutic Resistance
|
Ho, Matthew
|
|
|
20 |
10 |
p. e752-e768
|
artikel
|
| 23 |
Socioeconomic Status Is an Independent Prognostic Factor for Overall Survival in Patients With Multiple Myeloma: Real-World Data From a Cohort of 223 Patients
|
Intzes, Stergios
|
|
|
20 |
10 |
p. 704-711
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
20 |
10 |
p. A3-A7
|
artikel
|
| 25 |
The Use of Post-transplantation Cyclophosphamide in Peripheral Blood HLA-matched Stem Cell Transplantation as Graft-versus-host Disease Prophylaxis in Patients With Malignant or Non-malignant Hematologic Disorders: A Single-center Experience of 52 Patients
|
Mahmoud, Hossam Kamel
|
|
|
20 |
10 |
p. 677-684
|
artikel
|
| 26 |
Time to Redefine Risk-Stratification and Response Criteria in Immunoglobulin Light Chain Amyloidosis?
|
Jain, Ankur
|
|
|
20 |
10 |
p. e769-e776
|
artikel
|
| 27 |
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies
|
Leng, Siyang
|
|
|
20 |
10 |
p. e734-e751
|
artikel
|
| 28 |
Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma
|
Nathwani, Nitya
|
|
|
20 |
10 |
p. e667-e672
|
artikel
|
Tijdschrift beschrijving